Results 351 to 360 of about 928,338 (389)
Preparation of La<sub>2</sub>Sn<sub>2</sub>O<sub>7</sub>, Mg<sub>2</sub>SnO<sub>4</sub>, and MgSn(OH)<sub>6</sub> and their antiviral/antibacterial activities. [PDF]
J Mater Sci Mater MedKiribayashi R +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pharmaceutisch Weekblad, 1991
There are only a limited number of effective, non-toxic antiviral drugs for clinical use, whereas there is a great need for such drugs. Especially for the treatment of patients infected with the human immuno-deficiency virus (HIV) anti-HIV drugs are required. At the same time viral infections secondary to AIDS cannot yet be treated effectively.
R. Janknegt, E. H. H. Wiltink
openaire +3 more sources
There are only a limited number of effective, non-toxic antiviral drugs for clinical use, whereas there is a great need for such drugs. Especially for the treatment of patients infected with the human immuno-deficiency virus (HIV) anti-HIV drugs are required. At the same time viral infections secondary to AIDS cannot yet be treated effectively.
R. Janknegt, E. H. H. Wiltink
openaire +3 more sources
Mayo Clinic Proceedings, 1987
Amantadine is well established as the preferred antiviral agent for the prophylaxis of influenza A and may also be beneficial therapeutically when used early in the course of the disease. Idoxuridine is applicable only in the treatment of herpetic keratitis.
P E, Hermans, F R, Cockerill
openaire +3 more sources
Amantadine is well established as the preferred antiviral agent for the prophylaxis of influenza A and may also be beneficial therapeutically when used early in the course of the disease. Idoxuridine is applicable only in the treatment of herpetic keratitis.
P E, Hermans, F R, Cockerill
openaire +3 more sources
Pediatric Clinics of North America, 1995
The ability of viruses to develop resistance to antiviral agents is already a major concern with respect to HIV. This article reviews mechanisms and clinical correlates of antiviral resistance and alternative drugs for treatment of infections due to resistant strains of HIV, herpes simplex virus, cytomegalovirus, varicellazoster virus, and influenza A.
Stuart E. Starr +2 more
openaire +3 more sources
The ability of viruses to develop resistance to antiviral agents is already a major concern with respect to HIV. This article reviews mechanisms and clinical correlates of antiviral resistance and alternative drugs for treatment of infections due to resistant strains of HIV, herpes simplex virus, cytomegalovirus, varicellazoster virus, and influenza A.
Stuart E. Starr +2 more
openaire +3 more sources
New Antivirals and Antiviral Resistance
2004The field of antiviral therapy is relatively new. Whereas the first antibiotics were available in the 1940s, the first antiviral agent (idoxuridine) was not licensed until the 1960s. Furthermore, the number of antiviral agents available to clinicians today pale in comparison to the number of antibacterial agents.
openaire +3 more sources
Archives of Virology, 2007
Aptamers are rare nucleic acid ligands, which can be concocted in the laboratory from the randomized pool of molecules by affinity and amplification processes. Aptamers have several properties as they can be applied complementarily to antibodies and have several advantages over antibodies. In the past, several aptamers have been selected with a view to
openaire +3 more sources
Aptamers are rare nucleic acid ligands, which can be concocted in the laboratory from the randomized pool of molecules by affinity and amplification processes. Aptamers have several properties as they can be applied complementarily to antibodies and have several advantages over antibodies. In the past, several aptamers have been selected with a view to
openaire +3 more sources